Retinitis Pigmentosa
📧 Sign up to get email alerts when something new happens for Retinitis Pigmentosa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Cell Collection to Study Eye Diseases
An NEI-sponsored clinical trial update describes cell collection to study eye diseases, including age-related macular degeneration, retinal …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients [NA]
Clinical trial update on whether a capsular tension ring affects intraocular lens position in cataract patients with retinitis pigmentosa. T…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
An observational trial update evaluating the short-term effects of transcorneal electrical stimulation on visual performance in patients wit…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Rod and Cone Mediated Function in Retinal Disease
Clinical trial registry entry for a study of rod and cone mediated function in retinal disease, sponsored by the National Eye Institute, cur…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety of DSP-3077 given by unilateral intravitreal injection in adults with retinitis pigmento…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
A registry and natural history study investigating retinal dystrophies associated with rare disease-causing genetic variants; currently recr…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) [Phase 1, Phase 2]
A Phase 1/2 prospective, randomized, sham-controlled dose-finding trial assessing the safety and efficacy of ZM-02 Injection, a modified opt…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
This clinical trial update describes an ongoing natural history study of PRPF31 mutation-associated retinal dystrophy, an inherited retinal …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) [Phase 2]
Phase 2 clinical trial evaluating the safety of a single intravitreal injection of jCell (Famzeretcel) for Retinitis Pigmentosa; the study i…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) [Phase 1, Phase 2]
This clinical trial update reports that recruitment is ongoing for a Phase 1/2 study evaluating the safety of OpCT-001 in adults with primar…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Expanded Access Program for RP in Adults
The document notes that the expanded access program for Ocugen's retinitis pigmentosa treatment in adults is no longer available.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients [Phase 1, Phase 2]
A Phase 1/2 trial of a 9-cis beta-carotene-rich extract from Dunaliella algae in retinitis pigmentosa is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
Clinical trial update on the development and evaluation of functional visual field and navigation endpoints for moderate-to-profound inherit…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene [Phase 2]
Ultevursen is being evaluated in a Phase 2 trial for retinitis pigmentosa caused by USH2A exon 13 mutations, and recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases [Phase 1, Phase 2]
This clinical trial update notes a Phase 1/Phase 2 study evaluating subtenon autologous platelet-rich plasma for inherited and degenerative …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Rate of Progression in EYS Related Retinal Degeneration
Clinical trial update on the rate of progression in EYS-related retinal degeneration (Retinitis Pigmentosa); the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa [Phase 1, Phase 2]
GenSight Biologics is conducting a dose-escalation Phase 1/2 trial of GS030 to evaluate safety and tolerability in non-syndromic Retinitis P…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Oral N-acetylcysteine for Retinitis Pigmentosa [Phase 3]
Phase 3 trial of oral N-acetylcysteine for Retinitis Pigmentosa is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
Prospective observational study in adults with Retinitis Pigmentosa, sponsored by Sumitomo Pharma America, currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa [NA]
Clinical trial update noting an ongoing study evaluating electro-acupuncture and transcorneal electrical stimulation for retinitis pigmentos…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II [Phase 2, Phase 3]
Clinical trial update on using Umbilical Cord Mesenchymal Stem Cells (UC-MSC) and conditioned media (CM) to slow vision loss in Retinitis Pi…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
This clinical trial update describes a study assessing the long-term safety of umbilical cord-derived mesenchymal stem cell (UC-MSC) transpl…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) [Phase 1]
ENVISION is a Phase 1 trial evaluating the safety of RTx-015 injection in patients with retinitis pigmentosa or choroideremia; the study is …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) [Phase 1, Phase 2]
A Phase 1/2 clinical trial sponsored by Octant, Inc. is recruiting healthy volunteers and participants with autosomal dominant retinitis pig…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital [NA]
This entry reports a clinical trial at Quinze-Vingts Hospital evaluating a post-diagnostic announcement protocol for retinitis pigmentosa; t…